Imaging plays a key role in the diagnosis and monitoring of tumor diseases
Breast cancer
Imaging plays a key role in the diagnosis and follow-up of tumor diseases. With the harmonization of examination protocols and the introduction of uniformly structured and standardized reporting in radiology, data relating to tumour imaging is to be generated across all sites and securely networked. As the social significance of oncological diseases is set to increase significantly in the coming years, extensive data sets are urgently needed for the establishment of new image-based biomarkers for primary diagnostics, risk-adapted stratification, prognosis, understanding of the disease and therapy planning and monitoring. In the future, structured data management will create the prerequisites for processing radiological data on a large scale and in real time, applying machine learning methods and integrating other data sources (e.g. pathology, omics).
Persons involved:
Director:Prof. Dr. Michael Uder (University Hospital Erlangen)
Expert group leader:PD Dr. Sabine Ohlmeyer (University Hospital Erlangen)
Coordinator: Prof. Dr. Matthias May (University Hospital Erlangen)
Expert group members: Dr. David Kaufmann (University Hospital Augsburg) , Dr. Timo Trzaska (University Hospital Augsburg), Dr. Ramona Wudy (University Hospital Augsburg), Dr. Matthias Wetzer (University Hospital Augsburg). David Kaufmann (University Hospital Augsburg), Dr. Timo Trzaska (University Hospital Augsburg), Dr. Ramona Wudy (University Hospital Augsburg), Dr. Matthias Wetzl (University Hospital Erlangen), Dr. Maria Ingenerf (LMU Munich), PD Dr. Eva Maria Fallenberg (Klinikum rechts der Isar), Dr. Stefan Reischl (Klinikum rechts der Isar), Dr. Antonia Wiedemann (Klinikum rechts der Isar), Dr. Simone Hammer (University Hospital Regensburg), Dr. Stephanie Sauer (University Hospital Würzburg), Philipp Josef Kuhl (University Hospital Würzburg)
External reviewers: Prof.Dr. Evelyn Wenkel (Radiology Munich), PD Dr. Susanne Wienbeck (St. Jospeh-Stift Bremen)
